↓ Skip to main content

Dove Medical Press

Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review

Overview of attention for article published in Therapeutics and Clinical Risk Management, September 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
3 X users

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
66 Mendeley
Title
Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
Published in
Therapeutics and Clinical Risk Management, September 2021
DOI 10.2147/tcrm.s323387
Pubmed ID
Authors

Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma, Leonard C Gray

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 12%
Student > Ph. D. Student 6 9%
Student > Master 6 9%
Student > Postgraduate 4 6%
Student > Doctoral Student 3 5%
Other 11 17%
Unknown 28 42%
Readers by discipline Count As %
Medicine and Dentistry 8 12%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Nursing and Health Professions 6 9%
Neuroscience 5 8%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 8 12%
Unknown 30 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2022.
All research outputs
#2,262,644
of 25,392,582 outputs
Outputs from Therapeutics and Clinical Risk Management
#100
of 1,323 outputs
Outputs of similar age
#52,068
of 433,636 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 18 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,636 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.